Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001383832 | SCV001583113 | pathogenic | Tuberous sclerosis 2 | 2020-02-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Deletion of the region of the TSC2 gene that includes exon(s) 20 has been determined to be clinically significant (PMID: 11281455, 10205261, 17287951). Therefore, deletions that encompass that region are likely to disrupt protein function and cause disease. This variant has not been reported in the literature in individuals with TSC2-related conditions. This variant is an in-frame deletion of the genomic region encompassing exons 17-21 of the TSC2 gene. It preserves the integrity of the reading frame. |